Literature DB >> 3829122

Intracellular free calcium levels in mononuclear cells of patients with cystic fibrosis and normal controls.

M H Schöni, F Schöni-Affolter, D Jeffery, S Katz.   

Abstract

The time course of resting free intracellular calcium concentrations in isolated mononuclear blood cells following a one hour incubation period with the fluorescent dye quin2 was evaluated. Under equal experimental conditions, a slow time-dependent increase of intracellular free calcium in patients with cystic fibrosis and normal healthy controls was noted. Using regression analysis, cystic fibrosis patients were seen to exhibit significantly higher free intracellular calcium concentrations than the controls over the time span covered. At an arbitrarily selected time (60 minutes) the free calcium level was 143.7 +/- 4.3 nM (SEM) in the patients, and 125.5 +/- 2.6 nM in controls. From these data it is concluded that neglecting the time-dependent (Ca2+)i changes following quin2 incubation leads to over- and/or underestimation of the unstimulated resting, basic free calcium levels and prevents the detection of differences between normals and cystic fibrosis patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3829122     DOI: 10.1016/0143-4160(87)90036-4

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  2 in total

1.  Abnormal secretagogue-induced intracellular free Ca2+ regulation in cystic fibrosis nasal epithelial cells.

Authors:  L Reinlib; D J Jefferson; F C Marini; M Donowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

2.  Monocytes from cystic fibrosis patients are locked in an LPS tolerance state: down-regulation of TREM-1 as putative underlying mechanism.

Authors:  Carlos del Fresno; Vanesa Gómez-Piña; Vanesa Lores; Alessandra Soares-Schanoski; Irene Fernández-Ruiz; Blas Rojo; Rodolfo Alvarez-Sala; Ernesto Caballero-Garrido; Felipe García; Tania Veliz; Francisco Arnalich; Pablo Fuentes-Prior; Francisco García-Río; Eduardo López-Collazo
Journal:  PLoS One       Date:  2008-07-16       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.